Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michiko Yamaoka"'
Autor:
Yuki Shirakawa, Kunimasa Ohta, Shunsuke Miyake, Ayumi Kanemaru, Akari Kuwano, Kou Yonemaru, Shota Uchino, Michiko Yamaoka, Yuki Ito, Naofumi Ito, Takuichiro Hide, Naoki Shinojima, Akitake Mukasa, Hideyuki Saito, Hirofumi Jono
Publikováno v:
Cells, Vol 10, Iss 11, p 2970 (2021)
Although glioblastoma (GBM) stem-like cells (GSCs), which retain chemo-radio resistance and recurrence, are key prognostic factors in GBM patients, the molecular mechanisms of GSC development are largely unknown. Recently, several studies revealed th
Externí odkaz:
https://doaj.org/article/04990f342bea47d793822790bc2772e9
Autor:
Kazutaka Oda, Keisuke Matsushita, Junpei Unoki, Kazuya Ozeki, Hitomi Tanaka, Michiko Yamaoka, Nao Gunda, Yumi Shimomura, Yuka Nishimura, Ayami Yamaguchi, Yuki Ito, Aina Nishigaki, Yusuke Baba, Natsumi Michiwaki, Shota Uchino, Kayo Kurogi, Mai Horikawa, Naoya Matsumoto, Kou Yonemaru, Hitomi Arakaki, Taiki Katsume, Kaho Matsuyama, Hirofumi Jono, Hideyuki Saito
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 48:53-58
Autor:
Hirofumi Jono, Hideyuki Saito, Michiko Yamaoka, Akitake Mukasa, Naofumi Ito, Naoki Shinojima, Takuichiro Hide, Kunimasa Ohta, Yuki Ito, Yuki Shirakawa
Publikováno v:
Cancer Science
Glioblastoma multiforme (GBM), a lethal brain tumor developing in the white matter of the adult brain, contains a small population of GBM stem cells (GSCs), which potentially cause chemotherapeutic resistance and tumor recurrence. However, the mechan
Autor:
Kou Yonemaru, Naoki Shinojima, Kunimasa Ohta, Hideyuki Saito, Shunsuke Miyake, Hirofumi Jono, Naofumi Ito, Michiko Yamaoka, Yuki Ito, Akari Kuwano, Ayumi Kanemaru, Shota Uchino, Yuki Shirakawa, Takuichiro Hide, Akitake Mukasa
Publikováno v:
Cells
Cells, Vol 10, Iss 2970, p 2970 (2021)
Volume 10
Issue 11
Cells, Vol 10, Iss 2970, p 2970 (2021)
Volume 10
Issue 11
Although glioblastoma (GBM) stem-like cells (GSCs), which retain chemo-radio resistance and recurrence, are key prognostic factors in GBM patients, the molecular mechanisms of GSC development are largely unknown. Recently, several studies revealed th